Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.44 |
| ▸ | PRKDC | P78527 | 12/20 | 0.42 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.42 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.42 |
| ▸ | BRDT | Q58F21 | 2/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14883050 | 0.94 | ALOX5 (0.43) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL14725677 | 0.90 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL14725772 | 0.90 | ALOX5 (0.44) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL16472824 | 0.84 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL14882922 | 0.84 | PRKDC (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL14725671 | 0.84 | ALOX5 (0.52) | ALOX5PRKDCPIK3CDPIK3CBGGPS1 | |
| SCHEMBL9921013 | 0.84 | ALOX5 (0.43) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL16472938 | 0.84 | PRKDC (0.38) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL16472841 | 0.84 | PRKDC (0.38) | ALOX5PRKDCPIK3CDPIK3CBBRDT | |
| SCHEMBL14725744 | 0.83 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRDT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255084-B2 | Heterocyclic compound and organic light-emitting device containing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-09 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | TRPC1, TRPC4, TRPC6 | ALOX5 648/4885PRKDC 4431/4885PIK3CD 1227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.